scPharmaceuticals  logo
scPharmaceuticals SCPH
$ 3.49 3.87%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

scPharmaceuticals Financial Statements 2011-2024 | SCPH

Annual Financial Statements scPharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

210 M 200 M 118 M 173 M 112 M 69.6 M 37.8 M - - - - - -

Shares

38.5 M 28.4 M 27.4 M 27.3 M 18.6 M 18.6 M 2.96 M - - - - - -

Historical Prices

5.44 7.05 4.31 6.34 6.1 3.9 12.8 - - - - - -

Net Income

-54.8 M -36.8 M -28 M -32.2 M -33 M -29.4 M -23.8 M -24.4 M -10.5 M - - - -

Revenue

13.6 M - - - - - - - - - - - -

Cost of Revenue

3.81 M - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-55.4 M -36.2 M -25.8 M -29.9 M -32.9 M -29.7 M -23.4 M -17.9 M - - - - -

Interest Expense

8.12 M 3.3 M 2.58 M 2.59 M 1.77 M 1.43 M 797 K 6.51 M - - - - -

EBITDA

-55.4 M -36.1 M -25.8 M -29.9 M -32.5 M -29.3 M -23 M -17.9 M -10.9 M - - - -

Operating Expenses

- - 25.8 M 29.9 M 32.9 M 29.7 M - - - - - - -

General and Administrative Expenses

53.4 M 20.6 M 9.78 M 11.8 M 8.27 M 13.7 M 9.1 M 6.05 M 2.58 M - - - -

All numbers in USD currency

Quarterly Income Statement scPharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

46.6 M 39 M 39 M 36 M 38.8 M 38.7 M 37.8 M 34.3 M 27.4 M 27.4 M 27.4 M 27.4 M 27.4 M 27.4 M 27.3 M 27.3 M 27.3 M 23.4 M 20.2 M 19.4 M 18.6 M 18.6 M 18.6 M 18.6 M 18.6 M 18.5 M 18.5 M 18.5 M 1.08 M 1.07 M 1.07 M - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-35.1 M -17.1 M -14.1 M - -15.6 M -14.2 M -11.2 M - -10.2 M -9.7 M -7.73 M - -6.55 M -7.06 M -7.1 M - -9.04 M -8.3 M -7.09 M - -6.21 M -7.26 M -8.72 M - -5.76 M -9.85 M -8.73 M - -5.49 M -6.54 M -4.91 M - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

10 M 8.05 M 6.1 M - 3.8 M 1.64 M 2.06 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

3.31 M 2.3 M 1.78 M - 1.08 M 354 K 605 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-18.1 M -14.4 M -15.9 M - -14.8 M -13.7 M -11.6 M - -10 M -9.42 M -7.24 M - -5.9 M -6.46 M -6.74 M - -8.44 M -7.68 M -6.65 M - -6.29 M -7.34 M -8.85 M - -5.84 M -9.9 M -8.7 M - -5.25 M -6.52 M -4.96 M - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

1.85 M 2.13 M 2.1 M - 2.06 M 2.01 M 1.96 M - 377 K 447 K 518 K - 667 K 651 K 636 K - 655 K 639 K 636 K - 398 K 369 K 354 K - 360 K 359 K 342 K - 329 K 132 K 10 K - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-18.1 M -14.4 M -15.8 M - -14.8 M -13.7 M -11.5 M - -9.98 M -9.41 M -7.23 M - -5.9 M -6.45 M -6.73 M - -8.43 M -7.67 M -6.64 M - -6.28 M -7.33 M -8.84 M - -5.83 M -9.9 M -8.69 M - -5.24 M -6.52 M -4.96 M - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - 10 M 9.42 M 7.24 M - 5.9 M 6.46 M 6.74 M - 8.44 M 7.68 M 6.65 M - 6.29 M 7.34 M 8.85 M - 5.84 M 9.9 M 8.7 M - 5.25 M 6.52 M 4.96 M - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

21.3 M 17.5 M 17.4 M - 14.1 M 12.1 M 10.9 M - 6.28 M 4.28 M 2.89 M - 2.21 M 2.65 M 2.73 M - 3.32 M 2.54 M 2.5 M - 2 M 1.84 M 2.32 M - 1.94 M 5.05 M 4.65 M - 1.66 M 2.37 M 2.07 M - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency